Quadrant Capital Group’s Opko Health OPK Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-272
Closed -$311 2151
2026
Q1
$311 Buy
+272
New +$335 ﹤0.01% 2652
2024
Q1
Sell
-887
Closed -$1.34K 2758
2023
Q4
$1.34K Sell
887
-1,408
-61% -$2.04K ﹤0.01% 2527
2023
Q3
$3.67K Buy
2,295
+1,408
+159% +$2.56K ﹤0.01% 2252
2023
Q2
$1.93K Hold
887
﹤0.01% 2424
2023
Q1
$1.3K Hold
887
﹤0.01% 2505
2022
Q4
$1.11K Buy
+887
New +$1.4K ﹤0.01% 2527
2021
Q2
Sell
-2,000
Closed -$9K 2512
2021
Q1
$9K Buy
+2,000
New +$9.55K ﹤0.01% 1555
2017
Q1
Sell
-533
Closed -$4K 2110
2016
Q4
$4K Sell
533
-136
-20% -$1.41K ﹤0.01% 1315
2016
Q3
$7K Hold
669
﹤0.01% 1164
2016
Q2
$6K Buy
+669
New +$6.79K ﹤0.01% 1177

Other funds holding OPK

Quadrant Capital Group's OPK Position: Q2 2026 in Review

Quadrant Capital Group sold out of Opko Health (OPK) in Q2 2026, closing a stake of 272 shares — an estimated $311 sold.

Quadrant Capital Group first reported a position in OPK in Q2 2016 and held it in 10 quarters. The position peaked at $9K in Q1 2021. 223 funds tracked by Wall St. Rank hold OPK as of Q2 2026.

  • Quadrant Capital Group reported no remaining Opko Health position as of Q2 2026 after selling out during the quarter.
  • Quadrant Capital Group sold 272 Opko Health shares in Q2 2026, an estimated $311.
  • Quadrant Capital Group first reported a position in Opko Health in Q2 2016 and held it in 10 quarters.
  • Quadrant Capital Group's Opko Health position peaked at $9K in Q1 2021.
  • 223 funds tracked by Wall St. Rank held Opko Health as of Q2 2026.

Based on Quadrant Capital Group's 13F filing for Q2 2026, filed 14 Aug 2026.